When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Can Anyone Take Paxlovid for Covid? Doctors Explain. - AOL

   www.aol.com/anyone-paxlovid-covid-doctors...

   So before taking Paxlovid, tell your doctor about all the medications you take, Dr. Shankaran says. If you have kidney or liver problems or HIV, Paxlovid might not be recommended for you.

3. What You Need to Know About Paxlovid Rebound - AOL

   www.aol.com/know-paxlovid-rebound-200700263.html

   If a Paxlovid rebound occurs, it can happen two to eight days after completing the five-day course of Paxlovid, adds Dr. Kunza. “The symptoms are generally mild, and they do not warrant a second ...

4. Should you take a COVID-19 antiviral after getting infected ...

   www.aol.com/news/covid-19-antiviral-getting...

   Who can take Paxlovid or Lagevrio? Both treatments are for individuals that have mild to moderate COVID-19 symptoms in the last five days and are at a higher risk of getting more serious reactions.

5. What is COVID rebound? Doctors explain common symptoms ... - AOL

   www.aol.com/news/covid-rebound-doctors-explain...

   Earlier in the pandemic, COVID rebound was thought to be mostly caused by taking the antiviral treatment Paxlovid, as many of these patients would notice symptoms returning a few days after ...

6. Some people are experiencing 'Paxlovid rebound' after taking ...

   www.aol.com/news/people-experiencing-paxlovid...

   When the antiviral medication Paxlovid was approved in 2021 to treat COVID-19, doctors began noticing a trend among some patients: a rebound case of the virus. After treatment, some people would ...

7. 'If it's COVID, Paxlovid'? For many, it should be easier to ...

   www.aol.com/news/covid-paxlovid-many-easier...

   Some of the more common side effects after taking Paxlovid are developing a temporary metallic taste in the mouth, which occurs in about 6% of recipients, and diarrhea (3%).

8. Nirmatrelvir/ritonavir - Wikipedia

   en.wikipedia.org/wiki/Nirmatrelvir/ritonavir

   Research suggests that nirmatrelvir/ritonavir may minimize the risk of long COVID. [29] A 2025 recent report indicates that Paxlovid may benefit certain long COVID patients, though it remains unclear which individuals are most likely to respond. [40] A study examined 13 long COVID patients who underwent extended treatment with the antiviral ...

9. U.S. doctors reconsider Pfizer's Paxlovid for lower-risk ...

   www.aol.com/news/u-doctors-reconsider-pfizers...

   Use of Pfizer Inc's COVID-19 antiviral Paxlovid spiked this week, but some doctors are reconsidering the pills for lower-risk patients after a U.S. public health agency warned that symptoms can ...